Exclusive distributor of Aril® amniotic tissue for ophthalmic applications


Amniotic Tissue in Ophthalmology

The use of amniotic tissue has been successful in treating a variety
of ophthalmic conditions and diseases, including:1

  • Corneal ulcers including neurotrophic keratitis
  • Keratitis/endophthalmitis
  • Pterygium’ post-keratoplasty, glaucoma or cataract
  • Chemical trauma
  • Bullous keratopathy
  • Neoplasm of the ocular surface
  • Reconstruction of the conjunctiva and fornix
  • Corneal degeneration
  • Recurrent epithelial erosion
  • Primary and secondary limbal stem cell deficiency
  • Mucous membrane pemphigoid
  • Dystrophy
  • Mechanical trauma
  • Chronic Stevens-Johnson syndrome or Lyell’s syndrome
  • Reconstruction of the anophthalmic cavity
  • Physical trauma
  • Eyelid reconstruction
  • Dysfunctional tear syndrome


1. Stephenson, Michelle. “Newsletters.” Review of Ophthalmology® Treatment Options with Amniotic Membrane. Review of Ophthalmology, 5 Nov. 2015. Web. 12 May 2016.


IMPORTANT: The above applications are for reference purposes only. This information does not guarantee payment, and is not legal advice. It is the provider’s responsibility to check their Medicare LCD for proper coding and billing.




448 Deer Creek Trail, Hoschton, GA 30548 Tel: 706.654.3209 Fax: 706.654.0999
Copyrightᅠ© 2016ᅠBlythe Medical. All rights reserved.